LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LondonWallet
No Result
View All Result

More babies will need hospital treatment over RSV vaccine delay, says top doctor

Philip Roth by Philip Roth
September 4, 2023
in UK
More babies will need hospital treatment over RSV vaccine delay, says top doctor
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter



T

he nation’s top children’s doctor has warned a delay on a new vaccine to combat respiratory syncytial virus (RSV) will mean more babies and infants will need hospital treatment this winter.

Dr Camilla Kingdon, president of the Royal College of Paediatrics and Child Health (RCPCH) told The Independent she is frustrated with the delay.

“We’re frustrated that if we had acted sooner, we might have at least reduced the extent of the impact this winter and we’ve missed an opportunity there,” Dr Kingdon said.

You might also like

Duchess of Sussex says new Netflix deal is ‘sign of strength’ for partnership

What to know before buying your first life insurance plan – London Business News | London Wallet

Business growth strategies in the online casino industry for entrepreneurs – London Business News | London Wallet

“One of the aspects of winter that always fills us with dread, is that we know that we’ll end up having to stop elective surgical lists because our hospitals are at full capacity with all the infections that we see in winter.

“You’ve got to get ahead of the game. We’re really disappointed that the programme hasn’t been rolled out in a way that is going to make an impact for this winter, because we’ve been talking about this endlessly, but there’s been a delay in activating the programme.”

Read More

A Department of Health and Social Care spokesperson told The Independent: “The NHS already offers monoclonal antibodies which provide protection against RSV to infants at very high risk.

“We are developing plans for delivering wider infant and adult RSV programmes in collaboration with UKHSA, NHS England and manufacturers. We will update in due course.”

A vaccine for the virus was approved for use for elderly adults in the UK back in July, with the virus causing 175,000 GP visits, 14,000 people needing hospital treatment and 8,000 deaths for people over the age of 60 in the UK.

The Medicines and Healthcare products Regulatory Agency approved pharmaceutical company GSK’s jab, known as Arexvy.

A trial showed the jab had a high level of efficacy and that the vaccine is generally well tolerated.

The vaccine was found to be 94.1% effective at stopping severe infection.

Side effects from the jab were “transient, with mild to moderate severity”, the researchers wrote.

The most common side effects were headache, pain at the injection site, tiredness, or joint or muscle aches or pain.



Source link

Share30Tweet19
Previous Post

Matter Labs co-founder proposes ‘Ethereum Supreme Court’ for on-chain disputes

Next Post

Pressure on ministers to spell out plans for schools during concrete disruption

Philip Roth

Philip Roth

Recommended For You

Duchess of Sussex says new Netflix deal is ‘sign of strength’ for partnership
UK

Duchess of Sussex says new Netflix deal is ‘sign of strength’ for partnership

October 14, 2025
What to know before buying your first life insurance plan – London Business News | London Wallet
UK

What to know before buying your first life insurance plan – London Business News | London Wallet

October 14, 2025
Business growth strategies in the online casino industry for entrepreneurs – London Business News | London Wallet
UK

Business growth strategies in the online casino industry for entrepreneurs – London Business News | London Wallet

October 14, 2025
iMAD Research Inc. decodes smart meter adoption barriers across emerging markets – London Business News | London Wallet
UK

iMAD Research Inc. decodes smart meter adoption barriers across emerging markets – London Business News | London Wallet

October 14, 2025
Next Post
Pressure on ministers to spell out plans for schools during concrete disruption

Pressure on ministers to spell out plans for schools during concrete disruption

Related News

Immutable taps Fireblocks to help game developers manage digital assets

Immutable taps Fireblocks to help game developers manage digital assets

August 15, 2024
Monolithic vs. modular blockchains

Monolithic vs. modular blockchains

November 3, 2023
HMRC fined for fining 184,000 low earners for not filing return despite no tax owing – London Business News | London Wallet

HMRC fined for fining 184,000 low earners for not filing return despite no tax owing – London Business News | London Wallet

June 26, 2023

Browse by Category

  • Business Finance
  • Crypto
  • Industries
  • Investing
  • Markets
  • Opinion
  • Real Estate
  • UK

London Wallet

Read latest news about finance, business and investing

  • Contact
  • Privacy Policy
  • Terms & Conditions

© 2025 London Wallet - All Rights Reserved!

No Result
View All Result
  • Checkout
  • Contact
  • Home
  • Login/Register
  • My account
  • Privacy Policy
  • Terms and Conditions

© 2025 London Wallet - All Rights Reserved!

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?